...
首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >Electrophysiological Effects of Prucalopride,a Novel Enterokinetic Agent,on Isolated Atrial Myocytes from Patients Treated with beta-Adrenoceptor Antagonists
【24h】

Electrophysiological Effects of Prucalopride,a Novel Enterokinetic Agent,on Isolated Atrial Myocytes from Patients Treated with beta-Adrenoceptor Antagonists

机译:新型肠胃运动药物普鲁氯普利对β-肾上腺素受体拮抗剂治疗的离体心房肌细胞的电生理影响

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Prucalopride is a selective 5-hydroxytryptamine type 4 (5-HT_4) receptor agonist developed for the treatment of gastrointestinal disorders.The endogenous agonist 5-HT acting via 5-HT_4 receptors increases the L-type Ca~(2+) current (I_(CaL)) with potentially proarrhythmic consequences (Pau et al.,2003).The aims of this study were to investigate the effects of prucalopride on I_(CaL),action potentials,refractory period,and arrhythmic activity in human atrial myocytes,and to compare these with the effects of 5-HT,using the whole-cell perforated patch-clamp technique.Prucalopride (10~(-9) to 10~(-4) M) produced a concentration-dependent increase in I_(CaL) amplitude,with a maximum response at 10muM,from -5.3+-0.6 to -10.9+-1.5pA/pF (p < 0.05;n=22 cells,10 patients),without affecting its voltage-dependence.Subsequent application of 10muM 5-HT further increased I_(CaL) to -17.7 +- 2.8 pA/pF (p < 0.05;n=16 cells,9 patients).The increase in I_(CaL) by prucalopride,98+-15%,was significantly smaller than that by 5-HT,233+-26% (p < 0.05).Prucalopride (10muM) significantly increased the action potential duration at 50% repolarization (APD_(50)) from 12+-2 to 17+-3 ms (p < 0.05;n=22 cells,9 patients).Following washout of prucalopride,5-HT (10muM) increased APD_(50),to a greater extent,from 14 +- 3 to 32+-7 ms (p < 0.05;n=11 cells;8 patients).The APD_(75),APD_(90),and effective refractory period were unaffected by prucalopride or 5-HT.Furthermore,5-HT induced abnormal depolarizations in 27% of the cells studied,whereas prucalopride induced none (p < 0.05).In conclusion,in human atrial cells,prucalopride,at concentrations markedly above those used therapeutically,acted as partial agonist on I_(CaL) and APD_(50),with no effect on late repolarization or refractory period,and was devoid of arrhythmic activity.
机译:普鲁卡必利是为治疗胃肠道疾病而开发的选择性5-羟色胺4型(5-HT_4)受体激动剂,通过5-HT_4受体起作用的内源性激动剂5-HT增加L型Ca〜(2+)电流(I_ (CaL))可能会导致心律失常(Pau等人,2003)。本研究的目的是研究普考氯普利对人心房肌细胞I_(CaL),作用电位,不应期和心律失常活性的影响。使用全细胞穿孔膜片钳技术将其与5-HT的作用进行比较。普卢卡必利(10〜(-9)至10〜(-4)M)导致I_(CaL)浓度依赖性增加振幅,最大响应为10μM,从-5.3 + -0.6到-10.9 + -1.5pA / pF(p <0.05; n = 22个细胞,10例患者),不影响其电压依赖性。随后应用10μM5 -HT使I_(CaL)进一步增至-17.7±-2.8 pA / pF(p <0.05; n = 16细胞,9例)。普卡洛必利的I_(CaL)增加98 + -15%,显着比5-HT,233 + -26%更敏感(p <0.05)。普鲁卡必利(10μM)将50%复极(APD_(50))时的动作电位持续时间从12 + -2延长至17 + -3 ms (p <0.05; n = 22个细胞,9例患者)。普鲁卡必利洗脱后,5-HT(10μM)使APD_(50)增加,从14 +-3到32 + -7 ms(p < 0.05; n = 11个细胞; 8例).APD_(75),APD_(90)和有效不应期不受普鲁氯必利或5-HT的影响。此外,在27%的研究细胞中5-HT引起异常去极化总的来说,普鲁卡必利在人心房细胞中的浓度明显高于治疗性浓度,对I_(CaL)和APD_(50)起到部分激动剂的作用,对晚期复极没有影响。或不应期,没有心律不齐的活动。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号